MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1181 to 1200 of 166,322 approvalsPage 60 of 8317

Magnesium Sulfate Injection

Approval Number: 国药准字H20253604
Registration: Mar 11, 2025

Mycophenolate Sodium Enteric-coated Tablets

Approval Number: 国药准字HJ20250028
Registration: Mar 11, 2025
m/s mylan laboratories limited

Polyethylene Glycol Electrolytes Powder(III)

Approval Number: 国药准字H20253607
Registration: Mar 11, 2025

Clindamycin Phosphate Topical Solution

Approval Number: 国药准字H20253605
Registration: Mar 11, 2025

Lanthanum Carbonate Chewable Tablets

Approval Number: 国药准字H20253619
Registration: Mar 11, 2025

Betamethasone Sodium Phosphate Injection

Approval Number: 国药准字H20253583
Registration: Mar 11, 2025

Entecavir Oral Solution

Approval Number: 国药准字H20253587
Registration: Mar 11, 2025

Midazolam Hydrochloride Oral Solution

Approval Number: 国药准字H20253580
Registration: Mar 11, 2025

Polyvinyl Alcohol Eye Drops

Approval Number: 国药准字H20253595
Registration: Mar 11, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253575
Registration: Mar 11, 2025

Piracetam Injection

Approval Number: 国药准字H20253599
Registration: Mar 11, 2025

Naloxone Hydrochloride Injection

Approval Number: 国药准字H20253615
Registration: Mar 11, 2025

Nitroglycerin sublingual tablets

Approval Number: 国药准字H20253612
Registration: Mar 11, 2025

Edoxaban Tosilate Tablets

Approval Number: 国药准字H20253623
Registration: Mar 11, 2025

Vancomycin Hydrochloride for Oral Solution

Approval Number: 国药准字H20253609
Registration: Mar 11, 2025

Apremilast Tablets

Approval Number: 国药准字H20253578
Registration: Mar 11, 2025

Levosalbutamol Hydrochloride Nebuliser Solution

Approval Number: 国药准字H20253618
Registration: Mar 11, 2025

Ambroxol Hydrochloride Oral Solution

Approval Number: 国药准字HJ20250024
Registration: Mar 11, 2025

Potassium Chloride Oral Solution

Approval Number: 国药准字H20253589
Registration: Mar 11, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253574
Registration: Mar 11, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.